Literature DB >> 11278603

The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins.

F Jaulin-Bastard1, H Saito, A Le Bivic, V Ollendorff, S Marchetto, D Birnbaum, J P Borg.   

Abstract

Identification of protein complexes associated with the ERBB2/HER2 receptor may help unravel the mechanisms of its activation and regulation in normal and pathological situations. Interactions between ERBB2/HER2 and Src homology 2 or phosphotyrosine binding domain signaling proteins have been extensively studied. We have identified ERBIN and PICK1 as new binding partners for ERBB2/HER2 that associate with its carboxyl-terminal sequence through a PDZ (PSD-95/DLG/ZO-1) domain. This peptide sequence acts as a dominant retention or targeting basolateral signal for receptors in epithelial cells. ERBIN belongs to the newly described LAP (LRR and PDZ) protein family, whose function is crucial in non vertebrates for epithelial homeostasis. Whereas ERBIN appears to locate ERBB2/HER2 to the basolateral epithelium, PICK1 is thought to be involved in the clustering of receptors. We show here that ERBIN and PICK1 bind to ERBB2/HER2 with different mechanisms, and we propose that these interactions are regulated in cells. Since ERBIN and PICK1 tend to oligomerize, further complexity of protein networks may participate in ERBB2/HER2 functions and specificity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278603     DOI: 10.1074/jbc.M010032200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Neuregulin signaling via erbB receptor assemblies in the nervous system.

Authors:  Sean Murphy; Randy Krainock; Muly Tham
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  Basolateral targeting of ERBB2 is dependent on a novel bipartite juxtamembrane sorting signal but independent of the C-terminal ERBIN-binding domain.

Authors:  Christian Dillon; Anna Creer; Karen Kerr; Angelika Kümin; Clive Dickson
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

3.  Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis.

Authors:  Peter Nagy; Jeroen Claus; Thomas M Jovin; Donna J Arndt-Jovin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-02       Impact factor: 11.205

4.  TRP1 interacting PDZ-domain protein GIPC forms oligomers and is localized to intracellular vesicles in human melanocytes.

Authors:  Rajendra H Kedlaya; Kumar M R Bhat; Julie Mitchell; Steven J Darnell; Vijayasaradhi Setaluri
Journal:  Arch Biochem Biophys       Date:  2006-08-23       Impact factor: 4.013

5.  PDZ domain binding selectivity is optimized across the mouse proteome.

Authors:  Michael A Stiffler; Jiunn R Chen; Viara P Grantcharova; Ying Lei; Daniel Fuchs; John E Allen; Lioudmila A Zaslavskaia; Gavin MacBeath
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

6.  The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane.

Authors:  Camilla Haslekås; Kamilla Breen; Ketil W Pedersen; Lene E Johannessen; Espen Stang; Inger Helene Madshus
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

7.  Protein interacting with C-kinase 1 (PICK1) binding promiscuity relies on unconventional PSD-95/discs-large/ZO-1 homology (PDZ) binding modes for nonclass II PDZ ligands.

Authors:  Simon Erlendsson; Mette Rathje; Pétur O Heidarsson; Flemming M Poulsen; Kenneth L Madsen; Kaare Teilum; Ulrik Gether
Journal:  J Biol Chem       Date:  2014-07-13       Impact factor: 5.157

8.  PDZ binding to the BAR domain of PICK1 is elucidated by coarse-grained molecular dynamics.

Authors:  Yi He; Adam Liwo; Harel Weinstein; Harold A Scheraga
Journal:  J Mol Biol       Date:  2010-11-02       Impact factor: 5.469

9.  Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.

Authors:  Jaekwang Jeong; Jungmin Choi; Wonnam Kim; Pamela Dann; Farzin Takyar; Julia V Gefter; Peter A Friedman; John J Wysolmerski
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

10.  Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy.

Authors:  Cemil Ozcelik; Bettina Erdmann; Bernhard Pilz; Nina Wettschureck; Stefan Britsch; Norbert Hübner; Kenneth R Chien; Carmen Birchmeier; Alistair N Garratt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.